Ionis Pharmaceuticals (IONS) PT Raised to $64 at Needham & Company as ENDEAR Study Halted Early for Efficacy

Go back to Ionis Pharmaceuticals (IONS) PT Raised to $64 at Needham & Company as ENDEAR Study Halted Early for Efficacy
(NASDAQ: IONS) Delayed: 86.33 --0 (-0%)
Previous Close $86.33    52 Week High $62.68 
Open $86.33    52 Week Low $19.59 
Day High $86.33    P/E N/A 
Day Low $86.33    EPS $0.00 
Volume 2,795